West Pharmaceutical CEO Eric Green speaks at the 30th Annual Baron Investment Conference.
▬ Contents of this video ▬▬▬▬▬▬▬▬▬▬
0:00 - Introduction to West Pharmaceuticals
1:33 - 100 Years of Growth
7:21 - Products and New Innovations for Growth
18:27 - Responding to the COVID-19 Pandemic
23:22 - Capital Expenditures and Business Performance
26:37 - ESG, Philanthropy, and Community Involvement
29:31 - Preventing Drug Contamination
31:42 - Delivering Larger Molecule Drugs
34:15 - Drug Delivery Device Development
36:57 - Minimizing Manufacturing Defects
39:05 - Quality Control Challenges
----------------------------------
Investors should consider the investment objectives, risks, and charges and expenses of the investment carefully before investing. The prospectus and summary prospectuses contain this and other information about the Funds. You may obtain them from the Funds’ distributor, Baron Capital, Inc., by calling 1-800-99-BARON or visiting baronfunds.com. Please read them carefully before investing.
Risks: All investments are subject to risk and may lose value.
The discussions of the companies at the Conference are not intended as advice to any person regarding the advisability of investing in any particular security. The views expressed at the Conference reflect those of the respective speakers. Those views are not intended as recommendations or investment advice to any person and are subject to change at any time based on market and other conditions and Baron Capital has no obligation to update them. Baron Capital has provided website addresses of companies participating in our Investment Conference as a convenience to our attendees. Baron Capital is not responsible for the content of these sites.
Portfolio holdings as a percentage of net assets as of September 30, 2023 for securities mentioned are as follows: West Pharmaceutical Services, Inc. - Baron Asset Fund (2.9%), Baron Growth Fund (2.4%), Baron Health Care Fund (2.2%).
Portfolio holdings are subject to change. Current and future portfolio holdings are subject to risk.
BAMCO, Inc. is an investment adviser registered with the U.S. Securities and Exchange Commission (SEC). Baron Capital, Inc. is a broker-dealer registered with the SEC and member of the Financial Industry Regulatory Authority, Inc. (FINRA).